In a video interview, Ontada’s Carole Berini discusses validated substitutes for missing measures such as ECOG performance status in oncology real-world studies. She explains how these can increase sample size and improve representation of patient groups that are difficult to reach.
Why it matters: The interview addresses missing functional status data and patient representation in oncology real-world research.
Data, digital and AIAI summary
Read at Applied Clinical Trials